VOLUME
67 2006 NUMBER 11
Original Articles
1665 Acupuncture for Depression: A Randomized Controlled Trial. John
J. B. Allen, Rosa N. Schnyer, Andrea S. Chambers, Sabrina K. Hitt, Francisco
A. Moreno, and Rachel Manber
[Abstract]
[PDF]
1674 A Randomized, Double-Blind, Active-Control Study of Sertraline
Versus Venlafaxine XR in Major Depressive Disorder. Richard C. Shelton,
Kirsten L. Haman, Mark H. Rapaport, Ari Kiev, Ward T. Smith, Robert M. A.
Hirschfeld, R. Bruce Lydiard, John M. Zajecka, and David L. Dunner
[Abstract]
[PDF]
1682 The Boundary Between Hypochondriasis and Obsessive-Compulsive
Disorder: A Cross-Sectional Study From the Netherlands. Anja Greeven,
Anton J. L. M. van Balkom, Yanda R. van Rood, Patricia van Oppen, and Philip
Spinhoven
[Abstract]
[PDF]
1690 Prediction of Remission as a Combination of Symptomatic and
Functional Remission and Adequate Subjective Well-Being in 2960 Patients
With Schizophrenia. Martin Lambert, Benno G. Schimmelmann, Dieter Naber,
Alexander Schacht, Anne Karow, Thomas Wagner, and Joerg Czekalla
[Abstract]
[PDF]
1698 Adjunctive Topiramate Therapy in Patients Receiving a Mood
Stabilizer for Bipolar I Disorder: A Randomized, Placebo-Controlled Trial.
K. N. Roy Chengappa, Lesley K. Schwarzman, Joseph F. Hulihan, Jim Xiang,
and Norman R. Rosenthal, for the Clinical Affairs Product Support Study-168
Investigators
[Abstract]
[PDF]
1707 Remission in First-Episode Psychosis: Predictor Variables and
Symptom Improvement Patterns. Robin Emsley, Piet P. Oosthuizen, Martin
Kidd, Liezl Koen, Dana J. H. Niehaus, and H. Jadri Turner
[Abstract]
[PDF]
1713 The Brown Longitudinal Obsessive Compulsive Study: Treatments
Received and Patient Impressions of Improvement. [CME]
Maria C. Mancebo, Jane L. Eisen, Anthony Pinto, Benjamin D.
Greenberg, Ingrid R. Dyck, and Steven A. Rasmussen
[Abstract]
[PDF]
1721 Incidence and Time Course of Subsyndromal Symptoms in Patients With
Bipolar I Disorder: An Evaluation of 2 Placebo-Controlled Maintenance
Trials. Mark A. Frye, Lakshmi N. Yatham, Joseph R. Calabrese, Charles L.
Bowden, Terence A. Ketter, Trisha Suppes, Bryan E. Adams, and Thomas R.
Thompson
[Abstract]
[PDF]
1729 Efficacy and Tolerability of Open-Label Topiramate in the Treatment
of Sleep-Related Eating Disorder: A Retrospective Case Series. John W.
Winkelman
[Abstract]
[PDF]
1735 Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With
Obsessive-Compulsive Disorder. Francisco A. Moreno, Christopher B.
Wiegand, E. Keolani Taitano, and Pedro L. Delgado
[Abstract]
[PDF]
1741 Which Factors Predict Placebo Response in Anxiety Disorders and
Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram.
Dan J. Stein, David S. Baldwin, Ornah T. Dolberg, Nicolas Despiegel, and
Borwin Bandelow
[Abstract]
[PDF]
1747 Olanzapine Versus Risperidone in the Treatment of Manic or Mixed
States in Bipolar I Disorder: A Randomized, Double-Blind Trial. Roy H.
Perlis, Robert W. Baker, Carlos A. Zarate, Jr., Eileen B. Brown, Leslie M.
Schuh, Hassan H. Jamal, and Mauricio Tohen
[Abstract]
[PDF]
1754 A Cross-Sectional Study of the Prevalence of Cognitive and Physical
Symptoms During Long-Term Antidepressant Treatment. Maurizio Fava, Lesley
M. Graves, Franco Benazzi, Margaret J. Scalia, Dan V. Iosifescu, Jonathan E.
Alpert, and George I. Papakostas
[Abstract]
[PDF]
1760 Association Between Enhanced Soluble CD40 Ligand and Proinflammatory
and Prothrombotic States in Major Depressive Disorder: Pilot Observations on
the Effects of Selective Serotonin Reuptake Inhibitor Therapy. Roberto
Leo, Giorgio Di Lorenzo, Manfredi Tesauro, Cinzia Razzini, Giovanni B.
Forleo, Gaetano Chiricolo, Clarissa Cola, Marco Zanasi, Alfonso Troisi,
Alberto Siracusano, Renato Lauro, and Francesco Romeo
[Abstract]
[PDF]
1767 Escitalopram Maintenance Treatment for Prevention of Recurrent
Depression: A Randomized, Placebo-Controlled Trial. Susan G. Kornstein,
Anjana Bose, Dayong Li, Khalil G. Saikali, and Chetan Gandhi
[Abstract]
[PDF]
1776 Antidepressants and Driving Ability: Results From a Clinical Study.
Alexander Brunnauer, Gerd Laux, Elisabeth Geiger, Michael Soyka, and
Hans-Jürgen Möller
[Abstract]
[PDF]
Focus on Alzheimer's Disease and Related Disorders
1782 A 100-Year Update on Alzheimer's Disease and Related Disorders.
Eric M. Reiman
[PDF]
1784 Alzheimer's Disease A Century Later. Richard J. Caselli, Thomas
G. Beach, Roy Yaari, and Eric M. Reiman
[Abstract]
[PDF]
Academic Highlights
1801 New Developments in Addiction Treatment. [CME]
[PDF]
ASCP Corner
1813 Measurement-Based Psychiatry: Definitions of Response, Remission,
Stability, and Relapse in Schizophrenia. Stefan Leucht and John M. Kane
[PDF]
A Psychiatrist's Diary
1815 Until Death Do Us Part. Shyam K. Bhat
[PDF]
Letters To the Editor
1817 Manic Switch in a Patient With Treatment-Resistant Bipolar
Depression Treated With Modafinil. Jürgen Wolf, Ute Fiedler, Ion
Anghelescu, and Natascha Schwertfeger
[PDF]
1817 Diagnostic and Therapeutic Challenges in Narcolepsy-Related
Psychosis. Daniel Kondziella and Peter Arlien-Soborg
[PDF]
1819 Beneficial Effects of Prazosin for Visual Hallucinations Associated
With Chronic Cocaine Abuse. Andre M. Tapp, Annette Kennedy, Elaine R.
Peskind, and Murray A. Raskind
[PDF]
1820 Fluoxetine-Mirtazapine Interaction May Induce Restless Legs
Syndrome: Report of 3 Cases From a Clinical Trial. Keiko A.
Prospero-Garcia, Antonio Torres-Ruiz, Jesus Ramirez-Bermudez, Javier
Velazquez-Moctezuma, Yoaly Arana-Lechuga, and Guadalupe Teran-Perez
[PDF]
1820 Tactile Hallucinations Associated With Therapeutic Doses of
Bupropion in 2 Patients. Anthony Charuvastra and Deborah Yaeger
[PDF]
1821 Immediate Switching From Moclobemide to Duloxetine May Induce
Serotonin Syndrome. Alejandro Jimenez-Genchi
[PDF]
Book Reviews 1823
Electronic CME Activities
e15 The Art and Science of Switching of
Antipsychotic Medications, Part 1. Peter J. Weiden, Allan H. Young,
and Peter F. Buckley
e16 Medical Risk in Patients
With Bipolar Disorder and Schizophrenia. John W. Newcomer |